# Fermentation Products Originated from Bacillus subtilis Promote Hepatic–Intestinal Health in Largemouth Bass, Micropterus salmoides

**Authors:** Kaifang Liu, Shubin Liu, Dexiang Feng, Pengwei Xun, Hanjun Jiang, Yanwei Zhang, Gaoliang Yuan, Xusheng Guo

PMC · DOI: 10.3390/biology14060646 · Biology · 2025-06-02

## TL;DR

Fermentation products from Bacillus subtilis improve liver and gut health in largemouth bass without affecting growth, offering a potential green alternative to antibiotics in aquaculture.

## Contribution

The study introduces FP-WeiGuangSu as a novel, green feed additive that enhances antioxidant capacity and gut microbiota in largemouth bass.

## Key findings

- FPs reduced liver injury markers and enhanced antioxidant enzymes like SOD, CAT, and GSH-px in largemouth bass.
- FPs altered gut microbiota diversity, with Paenibacillus as a significant microbial marker and activated pathways for antibiotic and amino acid biosynthesis.
- A 1–3% FP dietary supplement improved liver and intestinal health, making it a promising alternative to antibiotics in aquaculture.

## Abstract

This study investigates the effects of fermentation products (FPs) from Bacillus subtilis on the antioxidant capacity and gut microbiota of Largemouth Bass (M. salmoides), with the fish fed experimental diets containing 0, 1%, 3% and 5% FPs. Although the short-term administration of FPs had no significant impact on the growth performance of Largemouth Bass, it reduced liver injury markers, enhanced antioxidant capacity, increased the expression of immunity and lipolysis-related genes, and significantly altered the diversity and structure of gut microbiota, with different groups having different microbial markers. The addition of FPs resulted in Paenibacillus being the most significant microbial marker, activated certain pathways, and changed microbial abundances in the Bugbase analysis. Our findings show that a dietary supplement of 1–3% FPs can enhance the antioxidant ability and improve the liver and intestine health of M. salmoides, making it a promising feed additive in aquaculture.

The fermentation product FP-WeiGuangSu is regarded as a novel, green and efficient antibiotic substitute. Such products constitute one of the principal strategies for addressing bacterial diseases in aquaculture in the future. This study investigates the effects of FPs derived from Bacillus subtilis on the antioxidant capacity and gut microbiota of Largemouth Bass (Micropterus salmoides). Experimental diets containing 0, 1%, 3% and 5% FPs (Control, H1, H2 and H3) were fed to M. salmoides. Although short-term administration of FPs exerted no significant influence on the growth performance of Largemouth Bass, serological findings demonstrated that supplementation with FPs decreased the contents of the liver injury markers ALT, AST and AKP, along with liver MDA content, and enhanced antioxidant capacity (SOD, CAT and GSH-px). Notably, the addition of 1% FPs significantly improved the systemic antioxidant performance (SOD, CAT, GSH-px and T-AOC). Moreover, the FP supplementation increased the expression levels of il-10 and IgM, and lipolysis-related genes. The results of gut microbiota analysis revealed that FPs significantly altered the diversity and structure of gut microbiota. The LEfSe results indicated that the microbial marker of the control group was Cetobacterium, those of the H1 group were Bacillus and Mycoplasma, those of the H2 group were Acinetobacter, Paenibacillus and g_unclassified_Rhizobiaceae, and that of the H3 group was Enterococcus. The most significant microbial marker upon the addition of FPs was Paenibacillus, and the pathways for biosynthesis of secondary metabolites, biosynthesis of antibiotics, and biosynthesis of amino acids were significantly activated. The Bugbase analysis results suggested that, compared with the control group, the abundance of anaerobic bacteria in the FP group decreased, while the abundance of microorganisms with mobile-element-containing and oxidative-stress-tolerant phenotypes increased. Hence, this study demonstrated that 1–3% FP dietary supplementation can be used to enhance antioxidant ability, and liver and intestine health of M. salmoides in the aquaculture industry and can be regarded as a promising feed additive in aquaculture.

## Linked entities

- **Genes:** IL10 (interleukin 10) [NCBI Gene 3586], CD40LG (CD40 ligand) [NCBI Gene 959]
- **Species:** Bacillus subtilis (taxon 1423), Micropterus salmoides (taxon 27706), Paenibacillus (taxon 44249), Cetobacterium (taxon 180162), Bacillus (taxon 1386), Mycoplasma (taxon 2093), Acinetobacter (taxon 469), Enterococcus (taxon 1350)

## Full-text entities

- **Diseases:** bacterial diseases (MESH:D001424), liver injury (MESH:D017093)
- **Chemicals:** amino acids (MESH:D000596), MDA (MESH:D015104)
- **Species:** Mycoplasma (genus) [taxon 2093], Micropterus salmoides (largemouth bass, species) [taxon 27706], Paenibacillus (genus) [taxon 44249], Bacillus subtilis (species) [taxon 1423], Enterococcus (genus) [taxon 1350], Cetobacterium (genus) [taxon 180162], Acinetobacter (genus) [taxon 469]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12189297/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12189297/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC12189297/full.md

---
Source: https://tomesphere.com/paper/PMC12189297